TY - JOUR
T1 - Modulating diseased skin with tissue engineering
T2 - Actinic purpura treated with Apligraf
AU - Banta, Meggan N.
AU - Kirsner, Robert S.
PY - 2002/12/1
Y1 - 2002/12/1
N2 - BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical "take." Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.
AB - BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical "take." Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.
UR - http://www.scopus.com/inward/record.url?scp=0036945576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036945576&partnerID=8YFLogxK
U2 - 10.1046/j.1524-4725.2002.02116.x
DO - 10.1046/j.1524-4725.2002.02116.x
M3 - Article
C2 - 12472487
AN - SCOPUS:0036945576
VL - 28
SP - 1103
EP - 1106
JO - Dermatologic Surgery
JF - Dermatologic Surgery
SN - 1076-0512
IS - 12
ER -